Symptoms and Care Options for IBS: December 14, 2022 to March 23, 2023

This activity will provide physicians and advanced-practice providers a good foundation of the symptoms, diagnostic approaches and treatment therapies for chronic idiopathic constipation) patients with irritable bowel syndrome with diarrhea (IBS-D) and IBS-C (constipation). Special emphasis will be placed on the exploration of newly approved agents and those on the horizon of clinical practice. Key topics to be discussed include the diagnosis of IBS, the safety and efficacy of recently approved pharmacologic agents, and optimizing treatment and patient management approaches.
When Dec 14, 2022 06:30 PM to
Mar 23, 2023 08:45 PM
Where Various Dates and Locations - See Below
Contact Name
Contact Phone (253) 432-4023
Add event to calendarvCal
iCal


Target Audience
This activity is focused on the educational needs of physicians, advanced-practice clinicians and others who care for patients who have contracted or at-risk for developing viral hepatitis. They can be found in hospitals, academic medical centers, private practice and community-based health centers and clinics.

Program Agenda (Times May Vary)
6:30 – 7:00pm
Registration and Check-in

7:00 – 7:15pm
Welcome and Introductions
Dinner is served

7:15 – 8:30pm
Presentation
• An overview of Irritable Bowel Syndrome (IBS-C and IBS-D)
     o Epidemiology
     o Clinical Presentation
     o Adult and Pediatric Patients
• Pathogenesis of IBS-D and IBS-C
• An updated classification system for IBS, the Rome IV diagnostic criteria
• Management of IBS and CIC Patients
     o Dietary approaches
     o Anti-spasmodic therapies
     o Dietary fiber supplements
     o Behavioral approaches
• Recently approved therapeutic agents for IBS-D and  IBS-C
• Patient care management for Advanced-practice clinicians and specialty nurses
• Introduction and explanation of sucrase isomaltase deficiency and how to avoid mistaking it for IBS-D
• When and how to refer a patient for more advanced care, diagnostics and treatment
• Questions and Discussion on clinical cases
• Re-Cap and Closing comments

8:30 – 8:45pm
Continued Q&A, Collegial Discussion and Networking

8:45pm
Program adjourns

Learning Objectives
Those who actively participate in this activity will be able to:
1. Explore the pathways and symptoms of those with Irritable Bowel Syndrome with Diarrhea and Constipation.
2. Summarize the underlying physiologic and psychological determinants of IBS symptoms.
3. Identify patients with IBS-C and IBS-D who are appropriate candidates for pharmacotherapy.
4. Review the diagnostic criteria and available tests.
5. Investigate behavioral approaches to address the stressors that may increase IBS symptoms and ways to minimize the effect.
6. Develop individualized treatment plans for patients with IBS and CIC by applying new clinical data.
7. Explore sucrase isomaltase (SI) deficiency and its similar symptoms to IBS-D.
8. Assist patients and their families to recognize the causes and treatments for IBS so they can partner with clinicians to manage symptoms and treatment - especially important for younger patients.
9. Review the benefits, efficacy, safety and mechanism of action of the most current FDA approved treatment options and OTC options.
10. Recognize when to refer patients to GI specialists and what therapeutic options may be available.

Registration Fees
There is no fee to attend this event but advance registration is requested to allow for event planning.

To Register
Click on a date and location below to register for a program

If online registration has closed you may still attend the event by registering as a walk-in the day of the program.

December 14, 2022 - McLean, VA
Venue: Virginia Association of Physician Assistants
Faculty: Anthony Lembo, MD: Harvard University
View the Course Flyer


March 8, 2023 - Houston, TX
Venue: Harris County Academy of Family Physicians
Faculty: Brooks Cash, MD: University of Texas Health Science
View the Course Flyer

March 23, 2022 - Westminster, CA
Venue: Vietnamese Physicians Association
Faculty: Fouad Moawad, MD: Scripps Health
View the Course Flyer


Joint Provider Statement
UofL CMEPD logoThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Louisville School of Medicine and SC Liver Research Consortium. The University of Louisville School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

 Designation Statement
The University of Louisville School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses - This program has been approved by the Kentucky Board of Nursing for 1.2 continuing education credits through University of Louisville Hospital, provider number 4-0068-12-22-1303. The Kentucky Board of Nursing approval of an individual nursing education provider does not constitute endorsement of program content. Completion criteria to obtain CE's: Attend entire session and complete the evaluation.

Jointly Provided By


Disclosure of Ineligible Company Support
This activity has been supported by an educational grants from TBA.

Accreditation Disclosure
As a provider accredited by the ACCME, the Office of CME&PD, School of Medicine, University of Louisville, must ensure balance, independence, objectivity, and scientific rigor in all its accredited educational activities. All Planners, faculty, reviewers, and other persons that affected the content of this CME activity were required to submit a financial disclosure form from which relevant conflicts of interest were determined. If any relevant financial relationship(s) with ineligible companies were disclosed, the materials each of them prepared for this program (or influenced) were peer-reviewed and determined to be without ineligible company bias, were considered fair and balanced in terms of therapeutic options, and presented evidence-based content. All relevant financial relationships with ineligible organizations have been mitigated prior to this activity.

Learner Consent Statement
Names or contact information of learners will not be shared with any ineligible company or its agents without the explicit consent of the individual learner.

CME Enduring Material Activity 
Welcome to On-line version of theSymptoms and Care Options for IBS. This Online CME Enduring Material will provide a good foundation of the symptoms, diagnostic approaches and treatment therapies for chronic idiopathic constipation) patients with irritable bowel syndrome with diarrhea (IBS-D) and IBS-C (constipation).

You will have to register and create a user profile before you are able to view the material.
Once you have finished viewing the material you can either close the presentation window or select the CME Publisher Portal window at the top of the screen to continue with your post-test, evaluation, and generation of your CME certificate.
CLICK HERE to go to the enduring material activity landing webpage. (Available Soon)